These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33660495)

  • 1. Computational prediction of CRISPR-impaired non-coding regulatory regions.
    Baumgarten N; Schmidt F; Wegner M; Hebel M; Kaulich M; Schulz MH
    Biol Chem; 2021 Jul; 402(8):973-982. PubMed ID: 33660495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
    Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
    Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
    Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.
    Klann TS; Black JB; Chellappan M; Safi A; Song L; Hilton IB; Crawford GE; Reddy TE; Gersbach CA
    Nat Biotechnol; 2017 Jun; 35(6):561-568. PubMed ID: 28369033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of CRISPR/Cas9 technology in sepsis research.
    Wu M; Hu N; Du X; Wei J
    Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Multiple Genome Modifications Induced by the CRISPR/Cas9 System.
    Ota S; Kawahara A
    Methods Mol Biol; 2016; 1451():53-63. PubMed ID: 27464800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR genetic screens to investigate neurological diseases.
    So RWL; Chung SW; Lau HHC; Watts JJ; Gaudette E; Al-Azzawi ZAM; Bishay J; Lin LT; Joung J; Wang X; Schmitt-Ulms G
    Mol Neurodegener; 2019 Nov; 14(1):41. PubMed ID: 31727120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CRISPR Platform for Targeted In Vivo Screens.
    Maranda V; Zhang Y; Vizeacoumar FS; Freywald A; Vizeacoumar FJ
    Methods Mol Biol; 2023; 2614():397-409. PubMed ID: 36587138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
    Montalbano A; Canver MC; Sanjana NE
    Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements.
    Liu SY; Yi GQ; Tang ZL; Chen B
    Yi Chuan; 2020 May; 42(5):435-443. PubMed ID: 32431295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making point mutations in Escherichia coli BL21 genome using the CRISPR-Cas9 system.
    Wang X; He J; Le K
    FEMS Microbiol Lett; 2018 Jul; 365(14):. PubMed ID: 29596631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
    Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Genomics via CRISPR-Cas.
    Ford K; McDonald D; Mali P
    J Mol Biol; 2019 Jan; 431(1):48-65. PubMed ID: 29959923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
    Potts MA; McDonald JA; Sutherland KD; Herold MJ
    Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.